Pain. Other soft tissue disorders, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Ketamine, 0.5mg / kg intravenous injection (by Abidi Pharmaceutical Company, Iran), one dose, zero minute of the study. Intervention 2: Intervention group: Morphine
Treatment - Drugs
Intervention group: Ketamine, 0.5mg / kg intravenous injection (by Abidi Pharmaceutical Company, Iran), one dose, zero minute of the study
Intervention group: Morphine, 1.0mg / kg slow injection (by Abidi Pharmaceutical Company, Iran), one dose, zero minute of the study
Sponsors
Vice chancellor for research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Fracture of long bones in upper or lower extremities caused by blunt and direct trauma referring to the emergency ward; needing inject-able sedative Exclusion criteria: History of psychiatric, liver and kidney diseases, stroke, asthma and other cardiac and respiratory diseases; weight of below 45 or above 155 kg; pregnant or breastfeeding women; pressure of above 18 or below 90 mm Hg; heart rate of below 50 or above 150 per minute; respiration rate of below 10 or above 30 per minute; reduced consciousness; blow to the head or eyes; multiple trauma; allergy to the sedatives used in the research; drug addiction; use of inject-able drugs; fracture in the parts other than long bones; fracture with dislocation or fracture with extreme displacement that requires a reduction ; open fracture; compartment syndrome; lack of tendency to participate in the project; receiving sedatives before the research
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Start the intervention, in minutes (30, 60, 90, 120, 180, 240) after the intervention. Method of measurement: Visual scale of pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: 0,30,60,120,180,240 minutes after intervention. Method of measurement: MmHg With manometer.;Respiratory rate. Timepoint: 0,30,60,120,180,240 minutes after intervention. Method of measurement: Count the respiration rate. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahide Azarfar
Mazandaran University of Medical Sciences
Outcome results
None listed